HEALTH

New TempleTouch thermometer to be sold at Walgreens

BY Allison Cerra

HOLLY SPRINGS, N.C. Medisim-USA is rolling out the newest addition to its TempleTouch line at Walgreens stores nationwide.

The new digital TempleTouch mini thermometer now is available at Walgreens locations across the country. It delivers clinically accurate core body temperature in six seconds by gently touching the thermometer to the temple in a convenient size. The thermometer’s features include memory recall and the ability to display temperature in Fahrenheit or Celsius according to the user’s preference.

The thermometer will retail at about $16, Medisim-USA said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Sensa products to hit GNC shelves

BY Michael Johnsen

MANHATTAN BEACH, Calif. Sensa Products on Wednesday announced the launch of its Sensa weight-loss system through GNC, marking the first time Sensa will be available at retail.

“GNC has consistently been at the forefront of the nutrition and weight-loss industry,” stated Don Ressler, CEO of Sensa Products. “With its commitment to quality products and customer service, GNC is the perfect retail partner for Sensa.”

Added Tasso Koken, GNC’s EVP merchandising, “Sensa’s clinical studies are an important addition to the weight-loss segment. We look forward to working with Sensa to broaden the market for these innovative products. GNC has traditionally been a leader in diet supplement products, and this national retail launch of the Sensa line will certainly continue that tradition.”

GNC will launch the 60-day Sensa kit in stores and the entire Sensa product line will be available on GNC.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FDA approves Sun’s generic Strattera

BY Allison Cerra

MUMBAI, India A generic drug maker has received regulatory approval for its version of an attention deficit hyperactivity disorder treatment.

Sun Pharmaceutical Industries’ subsidiary has received approval to market its generic version of Strattera (atomoxetine hydrochloride capsules), an ADHD drug for children ages 6 years and older, as well as teens and adults. Strattera is made and marketed by Eli Lilly.

Annual sales of branded and generic atomoxetine hydrochloride capsules are estimated to be more than $530 million.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?